DIVI S LABORATORIES LTD
Stock Price Chart
DIVI S LABORATORIES LTD
Divi's Laboratories Limited is an India-based company, which is engaged in pharmaceutical ingredients (APIs), intermediates and nutraceutical ingredients with predominance in exports. The Company’s products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Naproxen Sodium, Olmesartan Medoxomil, Pregabalin, Ticagrelor, Triprolidine HCl, Valacyclovir HCl, Valsartan, Venlafaxine HCl, Vigabatrin, and others. The Company is also engaged in custom synthesis (contract manufacturing services) of APIs and Intermediates for global innovator companies with a portfolio of products across diverse therapeutic areas. The Company’s subsidiaries include Divis Laboratories (USA) Inc. and Divi’s Laboratories Europe AG.
Key Valuation & Ratios
SWOT Analysis
- Strong ROCE (15.0%)
- Sound financial health
- Market leader position
- Valuation multiplier (30.0x)
- Susceptible to macro headwinds
- Expanding sector trends
- Operational automation
- Stiff domestic competition
- Regulatory policy changes
Pros & Cons
- Consistent return ratios
- Stable business snapshot
- Strong promoter support
- Premium P/E over sector median
- Raw material input inflation